Biomerica, Inc.
BMRA · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $7,006 | $78,052 | $155,131 | $354,851 |
| - Cash | $2,399 | $4,170 | $9,719 | $5,917 |
| + Debt | $458 | $785 | $1,082 | $1,380 |
| Enterprise Value | $5,065 | $74,667 | $146,494 | $350,313 |
| Revenue | $5,311 | $5,415 | $5,339 | $18,871 |
| % Growth | -1.9% | 1.4% | -71.7% | – |
| Gross Profit | $498 | $611 | $446 | $2,977 |
| % Margin | 9.4% | 11.3% | 8.4% | 15.8% |
| EBITDA | -$4,737 | -$5,993 | -$6,872 | -$3,939 |
| % Margin | -89.2% | -110.7% | -128.7% | -20.9% |
| Net Income | -$4,973 | -$5,978 | -$7,140 | -$4,531 |
| % Margin | -93.6% | -110.4% | -133.7% | -24% |
| EPS Diluted | -2.16 | -0.36 | -0.5 | -0.36 |
| % Growth | -500% | 28% | -38.9% | – |
| Operating Cash Flow | -$3,841 | -$5,361 | -$5,474 | -$481 |
| Capital Expenditures | -$37 | -$115 | -$78 | -$170 |
| Free Cash Flow | -$3,878 | -$5,476 | -$5,552 | -$651 |